Mori S, Aoki T, Sakuraoka Y, Shimizu T, et al. Predictors of Poor Pathological Response to Neoadjuvant Gemcitabine Plus S-1 Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma. Pancreas 2021 May 19. pii: 00006676-900000000-98250.
PMID: 34016892